Interestingly, STC2's expression was also associated with genetic alterations, including microsatellite instability (MSI) and tumor mutational burden (TMB), highlighting its potential involvement in genomic instability, a hallmark of cancer. The gene discussed is STC2; the disease is neoplasm.